Literature DB >> 24681602

Challenges and possible solutions to colorectal cancer screening for the underserved.

Samir Gupta1, Daniel A Sussman, Chyke A Doubeni, Daniel S Anderson, Lukejohn Day, Amar R Deshpande, B Joseph Elmunzer, Adeyinka O Laiyemo, Jeanette Mendez, Ma Somsouk, James Allison, Taft Bhuket, Zhuo Geng, Beverly B Green, Steven H Itzkowitz, Maria Elena Martinez.   

Abstract

Colorectal cancer (CRC) is a leading cause of cancer mortality worldwide. CRC incidence and mortality can be reduced through screening. However, in the United States, screening participation remains suboptimal, particularly among underserved populations such as the uninsured, recent immigrants, and racial/ethnic minority groups. Increasing screening rates among underserved populations will reduce the US burden of CRC. In this commentary focusing on underserved populations, we highlight the public health impact of CRC screening, list key challenges to screening the underserved, and review promising approaches to boost screening rates. We identify four key policy and research priorities to increase screening among underserved populations: 1) actively promote the message, "the best test is the one that gets done"; 2) develop and implement methods to identify unscreened individuals within underserved population groups for screening interventions; 3) develop and implement approaches for organized screening delivery; and 4) fund and enhance programs and policies that provide access to screening, diagnostic follow-up, and CRC treatment for underserved populations. This commentary represents the consensus of a diverse group of experts in cancer control and prevention, epidemiology, gastroenterology, and primary care from across the country who formed the Coalition to Boost Screening among the Underserved in the United States. The group was organized and held its first annual working group meeting in conjunction with the World Endoscopy Organization's annual Colorectal Cancer Screening Committee meeting during Digestive Disease Week 2012 in San Diego, California.

Entities:  

Mesh:

Year:  2014        PMID: 24681602      PMCID: PMC3982886          DOI: 10.1093/jnci/dju032

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  64 in total

1.  Breast and cervical cancer screening in a low-income managed care sample: the efficacy of physician letters and phone calls.

Authors:  P M Lantz; D Stencil; M T Lippert; S Beversdorf; L Jaros; P L Remington
Journal:  Am J Public Health       Date:  1995-06       Impact factor: 9.308

2.  Use of a patient navigator to increase colorectal cancer screening in an urban neighborhood health clinic.

Authors:  Lina Jandorf; Yahaira Gutierrez; Jaime Lopez; Jennifer Christie; Steven H Itzkowitz
Journal:  J Urban Health       Date:  2005-05-11       Impact factor: 3.671

3.  New York City's immigrant minorities. Reducing cancer health disparities.

Authors:  Francesca M Gany; Susan M Shah; Jyotsna Changrani
Journal:  Cancer       Date:  2006-10-15       Impact factor: 6.860

4.  Projected national impact of colorectal cancer screening on clinical and economic outcomes and health services demand.

Authors:  Uri Ladabaum; Kenneth Song
Journal:  Gastroenterology       Date:  2005-10       Impact factor: 22.682

5.  Association of insurance with cancer care utilization and outcomes.

Authors:  Elizabeth Ward; Michael Halpern; Nicole Schrag; Vilma Cokkinides; Carol DeSantis; Priti Bandi; Rebecca Siegel; Andrew Stewart; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2007-12-20       Impact factor: 508.702

6.  Patterns of colorectal cancer screening uptake among men and women in the United States.

Authors:  Helen I Meissner; Nancy Breen; Carrie N Klabunde; Sally W Vernon
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-02       Impact factor: 4.254

7.  Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study.

Authors:  J S Mandel; J H Bond; T R Church; D C Snover; G M Bradley; L M Schuman; F Ederer
Journal:  N Engl J Med       Date:  1993-05-13       Impact factor: 91.245

8.  Perceived barriers and benefits to colon cancer screening among African Americans in North Carolina: how does perception relate to screening behavior?

Authors:  Aimee S James; Marci Kramish Campbell; Marlyn Allicock Hudson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-06       Impact factor: 4.254

9.  Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial.

Authors:  Samir Gupta; Ethan A Halm; Don C Rockey; Marcia Hammons; Mark Koch; Elizabeth Carter; Luisa Valdez; Liyue Tong; Chul Ahn; Michael Kashner; Keith Argenbright; Jasmin Tiro; Zhuo Geng; Sandi Pruitt; Celette Sugg Skinner
Journal:  JAMA Intern Med       Date:  2013-10-14       Impact factor: 21.873

10.  Value of patient time invested in the colonoscopy screening process: time requirements for colonoscopy study.

Authors:  Daniel E Jonas; Louise B Russell; Robert S Sandler; Jon Chou; Michael Pignone
Journal:  Med Decis Making       Date:  2008 Jan-Feb       Impact factor: 2.583

View more
  92 in total

1.  Effects of some natural immunomodulatory compounds in combination with thalidomide on survival rate and tumor size in fibrosarcoma-bearing mice.

Authors:  Reza Aghebati Maleki; Dariush Shanehbandi; Saeed Sadigh Eteghad; Habib Zarredar; Fatemeh Zare Shahneh; Leili Aghebati Maleki; Mehrnosh Samavati; Hamed Asadi; Seyed Ehsan Mosavi; Afshin Habibzadeh; Mozhdeh Mohammadian; Behzad Baradaran
Journal:  Adv Pharm Bull       Date:  2014-08-25

2.  Colorectal cancer deaths attributable to nonuse of screening in the United States.

Authors:  Reinier G S Meester; Chyke A Doubeni; Iris Lansdorp-Vogelaar; S Lucas Goede; Theodore R Levin; Virginia P Quinn; Marjolein van Ballegooijen; Douglas A Corley; Ann G Zauber
Journal:  Ann Epidemiol       Date:  2014-12-05       Impact factor: 3.797

3.  Low Literacy Level Instructions and Reminder Calls Improve Patient Handling of Fecal Immunochemical Test Samples.

Authors:  Andrew Wang; Carly Rachocki; Jean A Shapiro; Rachel B Issaka; Ma Somsouk
Journal:  Clin Gastroenterol Hepatol       Date:  2018-11-29       Impact factor: 11.382

4.  'Simple and easy:' providers' and latinos' perceptions of the fecal immunochemical test (FIT) for colorectal cancer screening.

Authors:  Claudia X Aguado Loi; Dinorah Martinez Tyson; Enmanuel A Chavarria; Liliana Gutierrez; Lynne Klasko; Stacy Davis; Diana Lopez; Tracy Johns; Cathy D Meade; Clement K Gwede
Journal:  Ethn Health       Date:  2018-01-10       Impact factor: 2.772

5.  Evaluating Two Evidence-Based Intervention Strategies to Promote CRC Screening Among Latino Adults in a Primary Care Setting.

Authors:  Sheila F Castañeda; Balambal Bharti; Rebeca Aurora Espinoza-Giacinto; Valerie Sanchez; Shawne O'Connell; Fatima Muñoz; Sylvia Mercado; Marie Elena Meza; Wendy Rojas; Gregory A Talavera; Samir Gupta
Journal:  J Racial Ethn Health Disparities       Date:  2017-06-20

6.  Cancer-related Knowledge, Attitudes and Behaviors within the Latino Faith Community in South Los Angeles.

Authors:  Aziza Lucas-Wright; Petra Duran; Mohsen Bazargan; Claudia Vargas; Annette E Maxwell
Journal:  Ethn Dis       Date:  2019-04-18       Impact factor: 1.847

7.  Colorectal cancer screening in the United States: Trends from 2008 to 2015 and variation by health insurance coverage.

Authors:  Janet S de Moor; Robin A Cohen; Jean A Shapiro; Marion R Nadel; Susan A Sabatino; K Robin Yabroff; Stacey Fedewa; Richard Lee; V Paul Doria-Rose; Cheryl Altice; Carrie N Klabunde
Journal:  Prev Med       Date:  2018-05-03       Impact factor: 4.018

8.  Lay Beliefs About the Accuracy and Value of Cancer Screening.

Authors:  Megan C Roberts; Rebecca A Ferrer; Katharine A Rendle; Sarah C Kobrin; Stephen H Taplin; Bradford W Hesse; William M P Klein
Journal:  Am J Prev Med       Date:  2018-03-16       Impact factor: 5.043

9.  Evaluation of patient-focused interventions to promote colorectal cancer screening among new york state medicaid managed care patients.

Authors:  Heather L M Dacus; Victoria L Wagner; Elisè A Collins; Jacqueline M Matson; Margaret Gates; Sonja Hoover; Florence K L Tangka; Teri Larkins; Sujha Subramanian
Journal:  Cancer       Date:  2018-10-25       Impact factor: 6.860

10.  "BeneFITs" to increase colorectal cancer screening in priority populations.

Authors:  Beverly B Green; Gloria D Coronado
Journal:  JAMA Intern Med       Date:  2014-08       Impact factor: 21.873

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.